摘要
目的:探讨肾移植受者口服免疫抑制药环孢素(Cs A)浓度剂量的个体差异与代谢酶CYP3A4/5基因多态性的关系。方法:应用连接酶检测反应法分析221例肾移植受者CYP3A4 rs4646437C>T和CYP3A5 6986G>A基因型,考察其对术后服用Cs A后6个月内、6~24个月、超过24个月的Cs A体质量校正剂量谷浓度(C0_/D)和服药2h后浓度(C2/D)的影响。结果:不同CYP3A5 6986G>A基因型移植术后6个月内、6~24个月、24个月后C_0/D均有统计差异(P<0.05),C_0/D值CYP3A56986GG>GA>AA。不同基因型CYP3A4 rs4646437C>T、CYP3A5 6986G>A在移植术后24个月以上C_2/D均有明显差异(P<0.05),C_2/D值CYP3A4 CC>CT>TT,CYP3A5 GG>GA>AA。结论:不同CYP3A5 6986G>A基因型影响移植受者的C_0/D和C_2/D;不同CYP3A4 rs4646437C>T基因型影响移植受者的C_2/D,可作为移植术后Cs A个体化用药的参考指标。移植后用药时间不同,基因型对C_0/D和/或C_2/D的影响也不同。
Objective: To evaluate the correlation of inter-individual variation of cyclosporine dosage and blood concentration and CYP3A4 and CYP3A5 polymorphism in renal transplant recipients. Methods: Two hundred and twenty-one renal transplant recipients treated with eyclosporine were genotyped for CYP3A4 rs4646437C 〉 T and CYP3A5 6986G 〉 A using ligase detection reactions. The effects of genetic polymorphisms of CYP3A4 and CYP3A5 on cyclosporine trough concentration (C0/D) and 2 h post-dQse concentra- tion (C2/D) during the period of 6 months, 6-24 months and above 24 months after renal transplant were studied. Results: CYP3A5 6986G 〉 A genotype affected Co/D during the period of 6 months, 6-24 months and beyond 24 months ( P 〈 0.05 ) with the order of CYP3A5 6986GG 〉 GA 〉 AA. CYP3A4 rs4646437C 〉 T and CYP3A5 6986G 〉 A genotype affected C2/D during the period above 24 months (P 〈 0.05 ) with the order of CYP3A4 rs4646437 CC 〉 CT 〉 TY and CYP3A5 6986GG 〉 GA 〉 AA. Conclusion: CYP3A5 6986G 〉 A genotype affects Co/D and C2/D of cyelosporine, and CYP3A4 rs4646437 C 〉 T genotype affects C2/D of cyelosporine. The effects of genotypes are varied in different stages.
出处
《中国药师》
CAS
2017年第1期91-93,共3页
China Pharmacist
基金
国家自然科学基金项目(编号:81403010)
上海交通大学医学院科技基金项目(编号:JYY1201)